Ongoing evolution of response assessment in glioma: Where do we stand?

The investigation and development of recently introduced agents or radiological measurements caused emergent misunderstandings to the response assessment of glioma. To date, the classical Macdonald criteria and the response assessment of neuro-oncology (RANO) criteria have been used successively for...

Full description

Saved in:
Bibliographic Details
Published in:Glioma (Mumbai, India) India), 2018-01, Vol.1 (3), p.97-103
Main Authors: Yi, Li, Ming, Haolang, Yu, Shengping, Ren, Bingcheng, Yang, Xuejun
Format: Article
Language:English
Subjects:
Assessment
glioma
neuro-oncology
response assessment
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The investigation and development of recently introduced agents or radiological measurements caused emergent misunderstandings to the response assessment of glioma. To date, the classical Macdonald criteria and the response assessment of neuro-oncology (RANO) criteria have been used successively for the evaluation of glioma outcome. However, ongoing efforts on complementary assessments are necessary to combat this malignancy. In this review, we highlight the shortcomings of the current criteria and introduce the initiative effort of RANO guideline and its offspring. We also discuss some future barriers for accurate assessment of treatment response in glioma.
ISSN:2589-6113
2589-6121
DOI:10.4103/glioma.glioma_13_18